Dr. Mridu Gulati, MD

Dr. Gulati practices at Yale New Haven Psychiatric Hospital (York St) in New Haven, Connecticut.

Dr. Gulati's NPI, 1548243629, was assigned on November 22, 2005. Dr. Gulati graduated from New York University Grossman School of Medicine in 1997. Dr. Gulati holds Connecticut license 043225.

Dr. Gulati's primary practice is Yale New Haven Psychiatric Hospital (York St), at 20 York Street, New Haven, CT 06510. The practice phone is (203) 688-5900.

Dr. Gulati's primary practice is Yale New Haven Psychiatric Hospital (York St) in New Haven, Connecticut. Dr. Gulati is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Gulati to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gulati practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Gulati's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Gulati is licensed in Connecticut.

CMS data shows 749 Medicare services from Dr. Gulati across 10 procedure codes in 2024, for 160 Medicare patients. Medicare paid $36,452 for them.

CMS counts 160 Medicare patients who saw Dr. Gulati in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gulati's median patient age at 71, with 51% women.

In 2024, Dr. Gulati wrote 1,050 Medicare Part D claims for 154 patients. 61% of them were for generic drugs. CMS names the drug for 848 of them, across 19 drugs with 11 or more claims each, at $1,789,482 in total drug cost. In 2023, CMS named 849 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Gulati for performance year 2024, reported as part of a group. Dr. Gulati accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gulati as offering telehealth.

Dmand AI links 47 papers to Dr. Gulati, published from 2010 to 2025. 2021 was the busiest year, with 6. The most frequent topics are Lung, Lung Diseases, Interstitial and Pulmonary Fibrosis. Dr. Gulati has published most often in Chest. Dr. Gulati's most frequent co-authors are Carrie A. Redlich, MD, Danielle Elyse Antin-Ozerkis, MD and Denyse Dawn Lutchmansingh, MD.

Dmand AI links Dr. Gulati to 1 clinical trial. Conditions studied include Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis.

CMS Open Payments shows 120 general payments to Dr. Gulati from 3 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $59,962.

Dr. Gulati graduated from New York University Grossman School of Medicine in 1997.